Table of Contents 1 Relevant Concepts of Golimumab 1.1 Indications for Golimumab 1.2 Development of Golimumab in China 1.3 Governmental Approval of Golimumab in China 1.4 The Impact of COVID-19 on Golimumab sales in China 2 Sales of Golimumab in China, 2018-2020 2.1 Sales Value of Golimumab 2.1.1 Overall Sales Value 2.1.2 Sales Value by Regions 2.2 Sales Volume of Golimumab 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Regions 2.3 Sales of Golimumab by Dosage Form in China, 2018-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Golimumab Manufacturers in China, 2018-2020 3.1 Analysis of Market Share of Major Golimumab Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Janssen Biologics BV 3.2.1 Enterprise Profile 3.2.2 Sales of SIMPONI (Janssen Biologics BV's Golimumab) in China 4 Prices of Golimumab for Different Manufacturers in China, 2020-2021 4.1 Janssen Biologics BV (SIMPONI) 5 Prospect of Chinese Golimumab Market, 2021-2025 5.1 Influential Factors of Chinese Golimumab Market Development 5.1.1 The Impact of COVID-19 on Chinese Golimumab Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Golimumab Injection Registration in China Chart Sales Value of Golimumab Injection over the World Chart Sales Value of Golimumab Injection in China, 2018-2020 Chart Sales Value of Golimumab Injection in China by Regions, 2018-2020 Chart Sales Volume of Golimumab Injection in China, 2018-2020 Chart Sales Volume of Golimumab Injection in China by Regions, 2018-2020 Chart Market Share by Sales Value of Top Golimumab Manufacturers in China, 2018-2020 Chart Sales Value and Volume of SIMPONI in China, 2018-2020 Chart Referential Prices of SIMPONI in China by regions, 2020-2021 Chart Forecast on Sales Value of Golimumab in China, 2021-2025 Chart Forecast on Sales Volume of Golimumab in China, 2021-2025